Over the past three months, Aerpio Pharmaceuticals Inc. [ARPO] ended the trading day at $1.20 and exhibited a change of -46.67% with a 24 hour trading and reached upto the volume of 1.44M compared to its recorded trading volume of 19.28 million. ARPO generated a 1 year amount change with 110.53%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by -30.23% with an amount shift of -13.67% over the last month.
On 11, December 2020, Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 Trial. According to news published on Yahoo Finance, Primary endpoint achieved with twice-daily dose group at 28 day time point versus latanoprost control group.
Analyst Birdseye View:
The most recent analyst activity for Aerpio Pharmaceuticals Inc. [NASDAQ:ARPO] stock was on July 23, 2018, when it was Initiated with a Buy rating from Needham, which also raised its 12-month price target on the stock to $10. Before that, on December 09, 2020, BTIG Research Recapitulated a Buy rating and elevated its amount target to $4.
In the past 52 weeks of trading, this stock has oscillated between a low of $0.42 and a peak of $2.31. Right now, the middling Wall Street analyst 12-month amount mark is $1.75. At the most recent market close, shares of Aerpio Pharmaceuticals Inc. [NASDAQ:ARPO] were valued at $1.20. According to the average price forecast, investors can expect a potential return of -71.43%.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 0.46 and the whole liability to whole assets at 0.43. It shows enduring liability to the whole principal at 0.18 and enduring liability to assets at 0.00 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 1.1367 points at 1st support level, the second support level is making up to 1.0733. But as of 1st resistance point, this stock is sitting at 1.2567 and at 1.3133 for 2nd resistance point.
Aerpio Pharmaceuticals Inc. [ARPO] reported its earnings at -$0.12 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.14/share signifying the difference of 0.02 and 14.30% surprise value. Comparing the previous quarter ending of 12/30/2019, the stated earnings were -$0.11 calling estimates for -$0.12/share with the difference of 0.01 depicting the surprise of 8.30%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Aerpio Pharmaceuticals Inc. [NASDAQ:ARPO] is 19.70. Likewise, the Quick ratio is also the same, showing Cash ratio at 11.56. Now if looking for a valuation of this stock’s amount to book ratio is 0.69.
The most recent insider trade was by ORBIMED ADVISORS LLC, 10% Owner, and it was the sale of 21400.0 shares on Dec 08.